Background: Osteonecrosis of the femoral head is a common disorder which can lead to hip joint destruction usually necessitating total hip replacement. Methods: Quantitative micro-computed tomography, digital radiography and histology were used to characterize changes in bone microarchitecture and bone mineral density during the repair of the osteonecrotic femoral head as well as during the development of secondary osteoarthritis in the ipsilateral acetabulum. Osteonecrosis was induced surgically in 17 adult, male rabbits and the contralateral side was used as control. Results: At 4 weeks no changes in microarchitecture in the femoral head nor in the acetabulum were found. At 6 months the repair process led to an increase in bone mass in the trabecular region of the femoral head. However, a decrease in volumetric bone mineral density and an increase in apparent porosity were seen in the compact subchondral and cortical region of the osteonecrotic femoral head. At 6 months the subchondral bone of the osteoarthritic ipsilateral acetabulum was thicker, but had a lower volumetric bone mineral density and a higher apparent porosity. Conclusion: Resorption of necrotic compact bone may weaken the structural properties of the femoral head. Moreover, remodeling and resorption of subchondral bone may play a critical role in the disease process of osteoarthritis.

Keywords:
Osteonecrosis, Micro-computed tomography, Femoral head, Osteoarthritis, Subchondral bone, Acetabulum
1.
Assouline-Dayan, Y., C. Chang, A. Greenspan, Y. Shoenfeld, M.E. Gershwin (2002) Pathogenesis and natural history of osteonecrosis. Semin Arthritis Rheum 32: 94–124.
2.
Barou, O., D. Valentin, L. Vico, C. Tirode, A. Barbier, C. Alexandre, M.H. Lafage-Proust (2002) High-resolution three-dimensional micro-computed tomography detects bone loss and changes in trabecular architecture early: comparison with DEXA and bone histomorphometry in a rat model of disuse osteoporosis. Invest Radiol 37: 40–46.
3.
Batiste, D.L., A. Kirkley, S. Laverty, L.M. Thain, A.R. Spouge, J.S. Gati, P.J. Foster, D.W. Holdsworth (2004) High-resolution MRI and micro-CT in an ex vivo rabbit anterior cruciate ligament transection model of osteoarthritis. Osteoarthritis Cartilage 12: 614–626.
4.
Boss, J.H., I. Misselevich (2003) Osteonecrosis of the femoral head of laboratory animals: the lessons learned from a comparative study of osteonecrosis in man and experimental animals. Vet Pathol 40: 345–354.
5.
Boyd, S.K., R. Muller, T. Leonard, W. Herzog (2005) Long-term periarticular bone adaptation in a feline knee injury model for post-traumatic experimental osteoarthritis. Osteoarthritis Cartilage 13: 235–242.
6.
Brown, T.D., M.E. Way, A.B. Ferguson Jr. (1981) Mechanical characteristics of bone in femoral capital aseptic necrosis. Clin Orthop Relat Res 156: 240–247.
7.
Conzemius, M. G., T. D. Brown, Y. Zhang, R. A. Robinson (2002) A new animal model of femoral head osteonecrosis: one that progresses to human-like mechanical failure. J Orthop Res 20: 303–339.
8.
Ding, M., A. Odgaard, I. Hvid (2003) Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. J Bone Joint Surg Br 85: 906–912.
9.
Downey, D. J., P.A. Simkin, W.L. Lanzer, F.A. Matsen, 3rd (1988) Hydraulic resistance: a measure of vascular outflow obstruction in osteonecrosis. J Orthop Res 6: 272–278.
10.
Eckstein, F., C.R. Jacobs, B.R. Merz (1997) Mechanobiological adaptation of subchondral bone as a function of joint incongruity and loading. Med Eng Phys 19: 720–728.
11.
Glimcher, M.J. (1999) Cell biology during repair of osteonecrosis: implications for rational treatment. Acta Orthop Belg 65(suppl 1): 17–22.
12.
Glimcher, M. J., J.E. Kenzora (1979a) The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; commments on treatment. Clin Orthop Relat Res 140: 273–312.
13.
Glimcher, M.J., J.E. Kenzora (1979b) The biology of osteonecrosis of the human femoral head and its clinical implications. II. The pathological changes in the femoral head as an organ and in the hip joint. Clin Orthop Relat Res 139: 283–312.
14.
Glimcher, M.J., J.E. Kenzora (1979c) Nicolas Andry award. The biology of osteonecrosis of the human femoral head and its clinical implications. 1. Tissue biology. Clin Orthop Relat Res 138: 284–309.
15.
Grynpas, M.D., B. Alpert, I. Katz, I. Lieberman, K.P. Pritzker (1991) Subchondral bone in osteoarthritis. Calcif Tissue Int 49: 20–26.
16.
Hayami, T., M. Pickarski, G.A. Wesolowski, J. McLane, A. Bone, J. Destefano, G.A. Rodan, L.T. Duong (2004) The role of subchondral bone remodeling in osteoarthritis: reduction of cartilage degeneration and prevention of osteophyte formation by alendronate in the rat anterior cruciate ligament transection model. Arthritis Rheum 50: 1193–1206.
17.
Hayami, T., M. Pickarski, Y. Zhuo, G.A. Wesolowski, G.A. Rodan, L.T. Duong (2005) Characterization of articular cartilage and subchondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 38: 234–243.
18.
Hernigou, P., A. Poignard, A. Nogier, O. Manicom (2004) Fate of very small asymptomatic stage-I osteonecrotic lesions of the hip. J Bone Joint Surg Am 86-A: 2589–2593.
19.
Huffman, K.M., J.R. Bowers, Z. Dailiana, J.L. Huebner, J.R. Urbaniak, V.B. Kraus (2006) Synovial fluid metabolites in osteonecrosis, Rheumatology (Oxford) DOI:10.1093/rheumatology/kel302.
20.
Kato, S., H. Yamada, N. Terada, K. Masuda, M. E. Lenz, M. Morita, Y. Yoshihara, O. Henmi (2005) Joint biomarkers in idiopathic femoral head osteonecrosis: comparison with hip osteoarthritis. J Rheumatol 32: 1518–1523.
21.
Kenzora, J.E., R.E. Steele, Z.H. Yosipovitch, M.J. Glimcher (1978) Experimental osteonecrosis of the femoral head in adult rabbits. Clin Orthop Relat Res 130: 8–46.
22.
Kim, H.K., T.S. Randall, H. Bian, J. Jenkins, A. Garces, F. Bauss (2005) Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs. J Bone Joint Surg Am 87-A: 550–557.
23.
Kim, H.K., D.N. Skelton, E.J. Quigley (2004) Pathogenesis of metaphyseal radiolucent changes following ischemic necrosis of the capital femoral epiphysis in immature pigs: a preliminary report. J Bone Joint Surg Am 86-A: 129–135.
24.
Lai, K.A., W.J. Shen, C.Y. Yang, C.J. Shao, J.T. Hsu, R. M. Lin, (2005) The use of alendronate to prevent early collapse of the femoral head in patients with nontraumatic osteonecrosis: a randomized clinical study. J Bone Joint Surg Am 87: 2155–2159.
25.
Lavernia, C.J., R.J. Sierra, F.R. Grieco (1999) Osteonecrosis of the femoral head. J Am Acad Orthop Surg 7: 250–261.
26.
Little, D.G., R.A. Peat, A. McEvoy, P.R. Williams, E.J. Smith, P.A. Baldock (2003) Zoledronic acid treatment results in retention of femoral head structure after traumatic osteonecrosis in young Wistar rats. J Bone Miner Res 18: 2016–2022.
27.
Mankin, H.J. (1992) Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med 326: 1473–1479.
28.
McCreadie, B. R., R. W. Goulet, L. A Feldkamp, S. A. Goldstein (2001) Hierarchical structure of bone and micro-computed tomography. Adv Exp Med Biol 496: 67–83.
29.
Mont, M.A., D.S. Hungerford (1995) Non-traumatic avascular necrosis of the femoral head, J Bone Joint Surg Am 77: 459–474.
30.
Otsu, N. (1979) A threshold selection method from gray-level histograms. IEEE T Syst Man Cyb 9: 62–66.
31.
Pelletier, J.P. (2004) Rationale for the use of structure-modifying drugs and agents in the treatment of osteoarthritis. Osteoarthritis Cartilage 12(suppl A): S63–S68.
32.
Turner, C.H. (2002) Biomechanics of bone: determinants of skeletal fragility and bone quality. Osteoporos Int 13: 97–104.
33.
Wachsmuth, L., K. Engelke (2004) High-resolution imaging of osteoarthritis using microcomputed tomography. Methods Mol Med 101: 231–248.
34.
Wang, G.J., Q. Cui, G. Balian (2000) The Nicolas Andry award. The pathogenesis and prevention of steroid-induced osteonecrosis. Clin Orthop Relat Res 370: 295–310.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.